​
​

Sigilon Therapeutics Ownership | Who Owns Sigilon Therapeutics?

OverviewChart

Sigilon Therapeutics Ownership Summary

Sigilon Therapeutics is owned by 4.20% institutional investors, and 95.80% retail investors. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 1.54% of its assets in Sigilon Therapeutics shares.

SGTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSigilon Therapeutics4.20%-95.80%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustryBiotech Stocks 44.70%7.99%47.31%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20233516.67%17,713,3501.23%424.41%129.09%8-
Dec 31, 2022303.45%17,498,6853.31%425.64%1157.14%8-33.33%
Sep 30, 202229-9.38%16,937,301-0.82%424.46%7-12.50%12-14.29%
Jun 30, 202232-31.91%17,076,790-6.35%421.58%8-38.46%14-33.33%
Mar 31, 202247-6.00%18,233,840-3.61%421.37%13-53.57%2190.91%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O38.65K1.54%-
Fidelity Growth Company Fund28.23K1.12%-
Fidelity Growth Company K68.72K0.35%-
Fidelity Series Growth Company3.19K0.13%-
Fidelity Nasdaq Composite Index1.06K0.04%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 11, 2023ELI LILLY & Co-Buy$25.64M
Jul 01, 2021RUFFOLO ROBERT R-Sell$69.93K
Jun 02, 2021ANDERSON DANIEL GRIFFITH-Sell$2.00M
Dec 08, 2020ELI LILLY & Co-Buy$5.40M

Insider Transactions Trends

DateBuySell
2023 Q3--
2023 Q2--
2023 Q1--
2022 Q2--
2022 Q1--

SGTX Ownership FAQ

Who Owns Sigilon Therapeutics?

Sigilon Therapeutics shareholders are primarily institutional investors at 4.20%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Sigilon Therapeutics's industry, Biotech Stocks , is 44.70%, which Sigilon Therapeutics falls below.

Does Blackrock own Sigilon Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Sigilon Therapeutics.

Who is the top mutual fund holder of Sigilon Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Sigilon Therapeutics shares, with 1.54% of its total shares outstanding invested in 38.65K Sigilon Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools